European Centre for Marine Biotechnology Dunstaffnage Marine Laboratory Dunbeg, Oban,Argyll,Scotland,PA37 1QA
GlycoMar is uniquely focused on the drug development and discovery of novel therapies based on saccharide molecules from marine organisms. These molecules offer a unique drug development process therapeutic approach with an excellent safety profile. The company has developed a unique library of polysaccharides and glycosaminoglycans. The molecules have been the subject of compositional analysis and structural characterisation. Anti-inflammatory screening has shown a high hit rate of valuable activity, which is being developed for treatment of psoriasis, inflammatory bowel disease, and respiratory inflammatory disease in collaboration with a pharmaceutical partner. GlycoMar is seeking partners for its psoriasis and inflammatory bowel disease programme. GlycoMar is also interested to talk to commercial partners interested in testing out molecules in other disease indications.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling